Aortic Stenosis
Conditions
Interventions
None listed
Sponsors
Department of Cardiovascular medicine, Okayama University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: From April 2016 to March 2025, echocardiographic follow-up will be performed for patients with moderate or severe AS, with at least 6 months between the dates of the echocardiographic follow-up. Calcified tricuspid aortic valve stenosis
Exclusion criteria
Exclusion criteria: Bicuspid valve AS Congenital AS After AVR/TAVR dialysis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in AV peak velocity at 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in echocardiographic parameters at 6 and 12 months Change in aortic valve calcification score/calcification density at 12 months TAVR/SAVR Incidence of heart failure, cardiovascular death, and all-cause mortality | — |
Countries
Japan
Contacts
Public ContactHironobu Toda
Okayama University Hospital Department of Cardiovascular medicine
Outcome results
None listed